Literature DB >> 16781790

Variability of bladder filling in patients receiving radical radiotherapy to the prostate.

Una M O'Doherty1, Helen A McNair, Andrew R Norman, Elizabeth Miles, Simon Hooper, Mark Davies, Naomi Lincoln, Jan Balyckyi, Peter Childs, David P Dearnaley, Robert A Huddart.   

Abstract

BACKGROUND AND
PURPOSE: Patients receiving radical radiotherapy to the prostate are requested to maintain a full bladder to displace the dome of the bladder and small bowel from the target volume. This study investigated patients' ability to consistently maintain a full bladder throughout planning and treatment before (Study 1) and after (Study 2) the introduction of a patient information sheet. PATIENTS AND METHODS: Bladder volumes were measured on 41 patients at CT scanning, simulation and once weekly during treatment using a portable ultrasound device, BladderScan BVI 3000. Patients were asked their assessment of bladder fullness, time since last urination and the volume of fluid drank. A patient information sheet on bladder filling was then introduced and the study repeated on 25 patients (Study 2). The ultrasound bladder volumes measured at CT were compared to the CT scan data.
RESULTS: There was a strong correlation between the ultrasound and CT bladder volumes r = 0.88 (P < 0.01). There was a significant decrease between the volume at CT (mean 362 ml, SD 229 ml) and treatment (mean 251 ml, SD 171 ml) in Study 1 (P = 0.002). In Study 2 the mean volume at CT was 286 ml (SD 164 ml) compared to a mean of 312 ml (SD 196 ml) during treatment. The measured volume correlated with patient self-assessment (r = 0.47, P < 0.01). The median volume drank by patients in Study 2 was 350 ml (range 50-825 ml) compared to 450 ml (range 75-1500 ml) in Study 1.
CONCLUSIONS: Our initial results showed patients were unable to maintain a constant bladder volume during planning and treatment. Implementation of written bladder filling instructions was shown to improve bladder volume consistency.

Entities:  

Mesh:

Year:  2006        PMID: 16781790     DOI: 10.1016/j.radonc.2006.05.007

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  32 in total

1.  Assessing the daily consistency of bladder filling using an ultrasonic Bladderscan device in men receiving radical conformal radiotherapy for prostate cancer.

Authors:  S Hynds; C K McGarry; D M Mitchell; S Early; L Shum; D P Stewart; J A Harney; C R Cardwell; J M O'Sullivan
Journal:  Br J Radiol       Date:  2010-12-15       Impact factor: 3.039

2.  Moderate hypofractionation and simultaneous integrated boost by helical tomotherapy in prostate cancer: monoinstitutional report of acute tolerability assessment with different toxicity scales.

Authors:  Giuseppe Ferrera; Gianluca Mortellaro; Mariella Mannino; Giovanni Caminiti; Antonio Spera; Vanessa Figlia; Giuseppina Iacoviello; Gioacchino Di Paola; Rosario Mazzola; Antonio Lo Casto; Filippo Alongi; Maria Pia Pappalardo; Roberto Lagalla
Journal:  Radiol Med       Date:  2015-05-24       Impact factor: 3.469

3.  Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline.

Authors:  Scott C Morgan; Karen Hoffman; D Andrew Loblaw; Mark K Buyyounouski; Caroline Patton; Daniel Barocas; Soren Bentzen; Michael Chang; Jason Efstathiou; Patrick Greany; Per Halvorsen; Bridget F Koontz; Colleen Lawton; C Marc Leyrer; Daniel Lin; Michael Ray; Howard Sandler
Journal:  J Clin Oncol       Date:  2018-10-11       Impact factor: 44.544

4.  An assessment of interfractional bladder, rectum and vagina motion in postoperative cervical cancer based on daily cone-beam computed tomography.

Authors:  Xin Wang; Min Yu; Jin Wang; Renming Zhong; Yali Shen; Yaqin Zhao; Zhiping Li; Sen Bai; Feng Xu
Journal:  Mol Clin Oncol       Date:  2015-12-10

5.  Physical and clinical implications of radiotherapy treatment of prostate cancer using a full bladder protocol.

Authors:  Raffaella Cambria; Barbara A Jereczek-Fossa; Dario Zerini; Federica Cattani; Flavia Serafini; Rosa Luraschi; Guido Pedroli; Roberto Orecchia
Journal:  Strahlenther Onkol       Date:  2011-11-25       Impact factor: 3.621

6.  Variability in bladder volumes of full bladders in definitive radiotherapy for cases of localized prostate cancer.

Authors:  Naoki Nakamura; Naoto Shikama; Osamu Takahashi; Makiko Ito; Masatoshi Hashimoto; Masahiro Uematsu; Yukihiro Hama; Kenji Sekiguchi; Keiichi Nakagawa
Journal:  Strahlenther Onkol       Date:  2010-11-08       Impact factor: 3.621

7.  Prostate cancer treated with image-guided helical TomoTherapy® and image-guided LINAC-IMRT : Correlation between high-dose bladder volume, margin reduction, and genitourinary toxicity.

Authors:  Sonia Drozdz; Michael Schwedas; Henning Salz; Susan Foller; Thomas G Wendt
Journal:  Strahlenther Onkol       Date:  2016-01-07       Impact factor: 3.621

8.  Image-guided radiotherapy for prostate cancer. Implementation of ultrasound-based prostate localization for the analysis of inter- and intrafraction organ motion.

Authors:  Michael Pinkawa; Martin Pursch-Lee; Branka Asadpour; Bernd Gagel; Marc D Piroth; Jens Klotz; Sandra Nussen; Michael J Eble
Journal:  Strahlenther Onkol       Date:  2008-12-24       Impact factor: 3.621

9.  Compliance with bladder protocol during concurrent chemoradiation for cancer of the cervix and its impact on enteritis: A prospective observational study.

Authors:  Sweta Bandanatham; Janaki Manur Gururajachar; Mohan Kumar Somashekar
Journal:  Rep Pract Oncol Radiother       Date:  2018-02-02

10.  cExternal beam radiation results in minimal changes in post void residual urine volumes during the treatment of clinically localized prostate cancer.

Authors:  Peter F Orio; Gregory S Merrick; Zachariah A Allen; Wayne M Butler; Kent E Wallner; Brian S Kurko; Robert W Galbreath
Journal:  Radiat Oncol       Date:  2009-07-22       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.